# Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

> **NCT03487562** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWP14012 Amg
- **DRUG:** DWP14012 Bmg
- **DRUG:** Clarithromycin
- **DRUG:** Amoxicillin
- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT03487562
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-08
- **Primary completion:** 2019-01-11
- **Final completion:** 2019-01-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03487562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03487562, "Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03487562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*